Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-25-001332
Filing Date
2025-08-14
Accepted
2025-08-14 16:12:19
Documents
80
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lftp_10q.htm   iXBRL 10-Q 1149673
2 CERTIFICATION lsfp_ex311.htm EX-31.1 9573
3 CERTIFICATION lsfp_ex312.htm EX-31.2 9624
4 CERTIFICATION lsfp_ex321.htm EX-32.1 3510
5 CERTIFICATION lsfp_ex322.htm EX-32.2 3530
  Complete submission text file 0001096906-25-001332.txt   6063175

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lsfp-20250630.xsd EX-101.SCH 61517
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE lsfp-20250630_lab.xml EX-101.LAB 347656
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lsfp-20250630_cal.xml EX-101.CAL 67915
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lsfp-20250630_pre.xml EX-101.PRE 280831
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lsfp-20250630_def.xml EX-101.DEF 141152
83 EXTRACTED XBRL INSTANCE DOCUMENT lftp_10q_htm.xml XML 1083704
Mailing Address 14155 PINE ISLAND DRIVE JACKSONVILLE FL 32224
Business Address 14155 PINE ISLAND DRIVE JACKSONVILLE FL 32224 847-915-2446
LFTD PARTNERS INC. (Filer) CIK: 0001391135 (see all company filings)

EIN.: 870479286 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52520 | Film No.: 251219157
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)